Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:DMT NASDAQ:FTRP NYSE:PHM NASDAQ:TLT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDMTSmall PharmaC$0.15-6.3%C$0.15C$0.06▼C$0.22C$50.37M0.86296,159 shs1.89 million shsFTRPField Trip Health$1.12$2.76$0.71▼$6.41$65.20MN/A214,681 shsN/APHMPulteGroup$134.70-1.7%$123.37$88.07▼$149.47$26.58B1.262.15 million shs2.01 million shsTLTiShares 20+ Year Treasury Bond ETF$90.16+0.2%$86.98$83.29▼$101.64$50.41B0.0638.83 million shs24.79 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDMTSmall Pharma0.00%0.00%0.00%0.00%0.00%FTRPField Trip Health0.00%0.00%0.00%0.00%0.00%PHMPulteGroup0.00%-2.41%+6.47%+33.94%-1.71%TLTiShares 20+ Year Treasury Bond ETF0.00%+1.57%+4.11%+5.25%-10.42%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDMTSmall PharmaC$0.15-6.3%C$0.15C$0.06▼C$0.22C$50.37M0.86296,159 shs1.89 million shsFTRPField Trip Health$1.12$2.76$0.71▼$6.41$65.20MN/A214,681 shsN/APHMPulteGroup$134.70-1.7%$123.37$88.07▼$149.47$26.58B1.262.15 million shs2.01 million shsTLTiShares 20+ Year Treasury Bond ETF$90.16+0.2%$86.98$83.29▼$101.64$50.41B0.0638.83 million shs24.79 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDMTSmall Pharma0.00%0.00%0.00%0.00%0.00%FTRPField Trip Health0.00%0.00%0.00%0.00%0.00%PHMPulteGroup0.00%-2.41%+6.47%+33.94%-1.71%TLTiShares 20+ Year Treasury Bond ETF0.00%+1.57%+4.11%+5.25%-10.42%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDMTSmall Pharma 0.00N/AN/AN/AFTRPField Trip Health 0.00N/AN/AN/APHMPulteGroup 2.73Moderate Buy$136.461.30% UpsideTLTiShares 20+ Year Treasury Bond ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest FTRP, DMT, PHM, and TLT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/2/2025PHMPulteGroupWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$135.00 ➝ $150.008/29/2025PHMPulteGroupZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/13/2025PHMPulteGroupWedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$150.007/23/2025PHMPulteGroupUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$141.00 ➝ $150.007/23/2025PHMPulteGroupCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$128.00 ➝ $132.007/23/2025PHMPulteGroupRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$115.00 ➝ $140.007/23/2025PHMPulteGroupOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$132.00 ➝ $140.007/23/2025PHMPulteGroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$121.00 ➝ $123.007/23/2025PHMPulteGroupWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$125.00 ➝ $135.007/23/2025PHMPulteGroupRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$109.00 ➝ $112.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDMTSmall Pharma-C$1.16K-43,343.80C$0.13 per share1.13C$0.03 per share5.00FTRPField Trip Health$3.88M16.80N/AN/A$0.92 per share1.22PHMPulteGroup$17.95B1.48$13.97 per share9.64$59.87 per share2.25TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDMTSmall Pharma-C$19.31M-C$0.07N/A∞N/AN/A-116.90%-66.00%N/AFTRPField Trip Health-$43.63M-$0.77N/AN/AN/A-1,125.12%-62.71%-47.29%N/APHMPulteGroup$3.08B$13.3810.079.960.4015.50%21.01%14.73%10/21/2025 (Estimated)TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/A∞N/AN/AN/AN/AN/ALatest FTRP, DMT, PHM, and TLT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025PHMPulteGroup$2.92$3.03+$0.11$3.03$4.42 billion$4.40 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDMTSmall PharmaN/AN/AN/AN/AN/AFTRPField Trip HealthN/AN/AN/AN/AN/APHMPulteGroup$0.880.65%N/A6.58%7 YearsTLTiShares 20+ Year Treasury Bond ETF$3.864.28%N/AN/AN/ALatest FTRP, DMT, PHM, and TLT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/3/2025PHMPulteGroupquarterly$0.220.66%9/16/20259/16/202510/2/20258/29/2025TLTiShares 20+ Year Treasury Bond ETFmonthly$0.32814.6%9/2/20259/2/20259/5/20257/31/2025TLTiShares 20+ Year Treasury Bond ETFMonthly$0.33084.52%8/1/20258/1/20258/6/20256/30/2025TLTiShares 20+ Year Treasury Bond ETFMonthly$0.32834.47%7/1/20257/1/20257/7/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDMTSmall Pharma5.952.636.28FTRPField Trip Health0.408.208.20PHMPulteGroup0.130.770.77TLTiShares 20+ Year Treasury Bond ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDMTSmall Pharma0.67%FTRPField Trip Health16.84%PHMPulteGroup89.90%TLTiShares 20+ Year Treasury Bond ETF73.33%Insider OwnershipCompanyInsider OwnershipDMTSmall Pharma31.08%FTRPField Trip HealthN/APHMPulteGroup0.76%TLTiShares 20+ Year Treasury Bond ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDMTSmall Pharma13335.77 millionN/ANot OptionableFTRPField Trip Health10458.22 millionN/ANot OptionablePHMPulteGroup6,793197.30 million195.80 millionOptionableTLTiShares 20+ Year Treasury Bond ETFN/A559.10 millionN/AOptionableFTRP, DMT, PHM, and TLT HeadlinesRecent News About These CompaniesETFs Never Had It So Good — The Trillion-Dollar Moment Is Almost Here4 hours ago | benzinga.comFed Funds Rate Cuts Won't Necessarily Lower Residential Mortgage RatesSeptember 12 at 4:41 PM | seekingalpha.comTLT: Higher Term Premiums On The Incoming Rate-Cut BetsSeptember 11, 2025 | seekingalpha.comInflation And Unemployment Are Soaring–And The Fed Is Now TrappedSeptember 11, 2025 | benzinga.comTLT: Remember Last SeptemberSeptember 9, 2025 | seekingalpha.comTLT ETF Analysis As Outflows Slow Amid A Trump Tariff Silver Lining September 4, 2025 | talkmarkets.comA 12.2% Monthly Dividend from the World’s Safest Asset...September 2, 2025 | marketbeat.comInflation Fears Fuel The Bear SteepenerAugust 26, 2025 | seekingalpha.comCredit Spreads At Historical Lows, TLT Vs. VCLTAugust 24, 2025 | seekingalpha.comThis 12.2% Dividend Turns Safe Treasuries Into Monthly IncomeAugust 20, 2025 | investing.com3 Reasons the Market Can Rally, 2 Ways to Diversify If It Doesn't (TLT)...August 5, 2025 | marketbeat.comiShares 10-20 Year Treasury Bond ETF declares monthly distribution of $0.377287August 5, 2025 | msn.comVOO Slips, TLT Rises as July Jobs Report DisappointsAugust 2, 2025 | finance.yahoo.comBonds: Fiscal Discipline In DeclineAugust 1, 2025 | seekingalpha.comWhy Powell Is Right To Pause Despite Trump's ExasperationAugust 1, 2025 | seekingalpha.comTreasury To Flood The Market With T-BillsJuly 31, 2025 | seekingalpha.comHow Stablecoins Can Help The US Treasury Fund The Government's Fiscal DeficitJuly 24, 2025 | seekingalpha.comSharkey Howes Loads Up on 50,817 TLT SharesJuly 23, 2025 | fool.comTLT: Rate Expectations Down And Yields Up? It's All About The Term PremiumJuly 22, 2025 | seekingalpha.comTLT Slides as Fixed-Income Investors Brace for CPI ReportJuly 16, 2025 | finance.yahoo.comGovernor Waller Gets Candid About Fed's Balance Sheet Mismatch And LossesJuly 14, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 20255 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Potential Rate Cuts Could Benefit These FirmsBy Nathan Reiff | September 8, 2025FTRP, DMT, PHM, and TLT Company DescriptionsSmall Pharma CVE:DMTC$0.15 -0.01 (-6.25%) As of 10/20/2023Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom. As of October 23, 2023, Small Pharma Inc. operates as a subsidiary of Cybin Inc.Field Trip Health NASDAQ:FTRPField Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.PulteGroup NYSE:PHM$134.70 -2.40 (-1.75%) Closing price 03:59 PM EasternExtended Trading$134.50 -0.20 (-0.15%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States. It acquires and develops land primarily for residential purposes; and constructs housing on such land. The company also offers various home designs, including single-family detached, townhomes, condominiums, and duplexes under the Centex, Pulte Homes, Del Webb, DiVosta Homes, John Wieland Homes and Neighborhoods, and American West brand names. In addition, the company arranges financing through the origination of mortgage loans primarily for homebuyers; sells the servicing rights for the originated loans; and provides title insurance policies, and examination and closing services to homebuyers. PulteGroup, Inc. was founded in 1950 and is headquartered in Atlanta, Georgia.iShares 20+ Year Treasury Bond ETF NASDAQ:TLT$90.16 +0.21 (+0.23%) Closing price 04:00 PM EasternExtended Trading$90.23 +0.07 (+0.08%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years. The Underlying Index includes all publicly-issued the United States Treasury securities that have a remaining maturity of greater than or equal to 20 years. BlackRock Fund Advisors serves as investment adviser of the Fund. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
